查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
微生物组定序服务市场：趋势、机会与竞争分析 [2023-2028]
市场调查报告书
商品编码
1341985

微生物组定序服务市场：趋势、机会与竞争分析 [2023-2028]

Microbiome Sequencing Service Market: Trends, Opportunities and Competitive Analysis [2023-2028]
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

微生物组定序服务市场趋势与预测

预计到 2028 年，全球微生物组定序服务市场将达到 24 亿美元，2023 年至 2028 年年复合成长率为 12.4%。该市场的主要促进因素是对宏基因组分析技术的需求不断增长、对人类微生物组疗法市场开拓的高度关注以及与先进测序设备相关的高成本。全球微生物组定序服务市场前景广阔，为製药公司、生技公司和学术研究机构带来商机。

微生物组定序服务市场洞察

  • Lucintel 是一种高度并行的架构，能够同时对数百万个扩增子进行定序，并且对研究肠道、皮肤和其他器官中的细菌种群感兴趣，每个细菌种群都具有不同的微生物指纹。我们预测合成定序（SBS）在预测期内仍将是成长最快的部分，因为此外，它是一些商业公司广泛使用的技术。
  • 在这个市场中，由于研究和领域广泛使用微生物组定序服务进行蛋白质和小分子测试，学术和研究机构仍将是最大的最终用途产业领域。
  • 由于其完善的研究框架、尖端的技术发展以及该地区对精准医疗的需求不断增长，北美在预测期内可能仍然是最大的地区。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2.哪个细分市场将以更快的速度成长？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要要素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些，由于材料或产品替代导致市场占有率下降的威胁有多大？
  • Q.11.过去年度发生了哪些併购事件，对产业产生了哪些影响？

目录

第1章执行摘要

第2章全球微生物组定序服务市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业促进因素与挑战

第3章2017-2028年市场趋势及预测分析

  • 宏观经济趋势（2017-2022）与预测（2023-2028）
  • 全球微生物组定序服务市场趋势（2017-2022）与预测（2023-2028）
  • 按技术分類的全球微生物定序服务市场
    • 边合成边序列测定(SBS)
    • 连接定序 (SBL)
    • 奈米孔定序
    • 桑格序列测定
    • 其他的
  • 按类型分類的全球微生物组定序服务市场
    • 扩增子序列测定
    • 全基因组序列测定
    • 霰弹枪序列
    • 其他的
  • 按最终用途行业分類的全球微生物组定序服务市场
    • 製药和生物技术公司
    • 学术研究所
    • 其他的

第4章2017-2028年分地区市场趋势及预测分析

  • 全球微生物组定序服务市场（按地区）
  • 北美微生物组定序服务市场
  • 欧洲微生物组定序服务市场
  • 欧洲微生物组定序服务市场
  • 亚太微生物组定序服务市场
  • 其他区域微生物组定序服务市场

第5章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第6章成长机会与策略分析

  • 成长机会分析
    • 全球微生物组定序服务市场成长机会（按技术）
    • 按类型分類的全球微生物组定序服务市场成长机会
    • 最终用途产业的全球微生物组定序服务市场成长机会
    • 全球微生物组定序服务市场成长机会（按地区）
  • 全球微生物组定序服务市场的新兴趋势
  • 战略分析
    • 新产品开发
    • 全球微生物组定序服务市场容量扩张
    • 全球微生物组定序服务市场的合併、收购及合资企业
    • 认证和许可

第7章主要企业概况

  • Microbiome Insights
  • Baseclear
  • Clinical-Microbiomics
  • Merieux NutriSciences Corporation
  • MR DNA
  • Metabiomics
  • Rancho BioSciences
  • Second Genome
  • Zymo Research Corporation
  • uBiome
简介目录

Microbiome Sequencing Service Market Trends and Forecast

The future of the global microbiome sequencing service market looks promising with opportunities in pharmaceutical and biotechnology companies and academic and research institutes. The global microbiome sequencing service market is expected to reach an estimated $2.4 billion by 2028 with a CAGR of 12.4% from 2023 to 2028. The major drivers for this market are increasing demand for metagenomic sequencing technology, high concentration on development of human microbiome therapeutics, as well as high costs associated with sophisticated sequencing instruments.

A more than 150-page report is developed to help in your business decisions.

Microbiome Sequencing Service Market by Segment

The study includes trends and forecast for the global microbiome sequencing service market by technology, type, and end use industry, and region.

Microbiome Sequencing Service Market by Technology [Shipment Analysis by Value from 2017 to 2028]:

  • Sequencing by Synthesis (SBS)
  • Sequencing by Ligation (SBL)
  • Nanopore Sequencing
  • Sanger Sequencing
  • Others

Microbiome Sequencing Service Market by Type [Shipment Analysis by Value from 2017 to 2028]:

  • Amplicon Sequencing
  • Whole-Genome Sequencing
  • Shotgun Sequencing
  • Others

Microbiome Sequencing Service Market by End Use Industry [Shipment Analysis by Value from 2017 to 2028]:

  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • Others

List of Microbiome Sequencing Service Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, microbiome sequencing service companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the microbiome sequencing service companies profiled in this report include:

  • Microbiome Insights
  • Baseclear
  • Clinical-Microbiomics
  • Merieux NutriSciences Corporation
  • MR DNA
  • Metabiomics
  • Rancho BioSciences
  • Second Genome
  • Zymo Research Corporation
  • uBiome

Microbiome Sequencing Service Market Insights

  • Lucintel forecasts that sequencing by synthesis (SBS) will remain the highest growing segment over the forecast period due to its highly parallel structure that enables the simultaneous sequencing of millions of amplicons and increased interest in studying bacterial populations in the gut, skin, and other organs, each of which has a distinct microbial fingerprint. Moreover, it is an extensively used method by several commercial companies.
  • Within this market, academic and research institutes will remain the largest end use industry segment due to extensive utilization of microbiome sequencing services for the examination of proteins and small molecules within the research and academic sectors.
  • North America will remain the largest region over the forecast period due to well-developed research framework, cutting-edge technological progress, and the growing need for precision medicines in this region.

Features of the Global Microbiome Sequencing Service Market

  • Market Size Estimates: Microbiome sequencing service market size estimation in terms of value ($B).
  • Trend and Forecast Analysis: Market trends (2017 to 2022) and forecast (2023 to 2028) by various segments and regions.
  • Segmentation Analysis: Microbiome sequencing service market size by various segments, such as by technology, type, end use industry, and region in terms of value ($B).
  • Regional Analysis: Microbiome sequencing service market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different technologies, types, end use industries, and regions for the microbiome sequencing service market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the microbiome sequencing service market.
  • Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

  • Q.1. What is the microbiome sequencing service market size?
  • Answer: The global microbiome sequencing service market is expected to reach an estimated $2.4 billion by 2028.
  • Q.2. What is the growth forecast for microbiome sequencing service market?
  • Answer: The global microbiome sequencing service market is expected to grow with a CAGR of 12.4% from 2023 to 2028
  • Q.3. What are the major drivers influencing the growth of the microbiome sequencing service market?
  • Answer: The major drivers for this market are increasing demand for metagenomic sequencing technology, high concentration on development of human microbiome therapeutics, as well as high costs associated with sophisticated sequencing instruments.
  • Q4. What are the major segments for microbiome sequencing service market?
  • Answer: The future of the global microbiome sequencing service market looks promising with opportunities in pharmaceutical and biotechnology companies and academic and research institutes.
  • Q5. Who are the key microbiome sequencing service companies?
  • Answer: Some of the key microbiome sequencing service companies are as follows:
    • Microbiome Insights
    • Baseclear
    • Clinical-Microbiomics
    • Merieux NutriSciences Corporation
    • MR DNA
    • Metabiomics
    • Rancho BioSciences
    • Second Genome
    • Zymo Research Corporation
    • uBiome
  • Q6. Which microbiome sequencing service market segment will be the largest in future?
  • Answer: Lucintel forecasts that sequencing by synthesis (SBS) will remain the highest growing segment over the forecast period due to its highly parallel structure that enables the simultaneous sequencing of millions of amplicons and increased interest in studying bacterial populations in the gut, skin, and other organs, each of which has a distinct microbial fingerprint. Moreover, it is an extensively used method by several commercial companies.
  • Q7. In microbiome sequencing service market, which region is expected to be the largest in next 5 years?
  • Answer: North America will remain the largest region over the forecast period due to well-developed research framework, cutting-edge technological progress, and the growing need for precision medicines in this region.
  • Q.8. Do we receive customization in this report?
  • Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the global microbiome sequencing service market by technology (sequencing by synthesis (SBS), sequencing by ligation (SBL), nanopore sequencing, sanger sequencing, and others), type (amplicon sequencing, whole-genome sequencing, shotgun sequencing, and others), end use industry (pharmaceutical and biotechnology companies, academic and research institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last five years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Microbiome Sequencing Service Market: Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2017 to 2028

  • 3.1: Macroeconomic Trends (2017-2022) and Forecast (2023-2028)
  • 3.2: Global Microbiome Sequencing Service Market Trends (2017-2022) and Forecast (2023-2028)
  • 3.3: Global Microbiome Sequencing Service Market by Technology
    • 3.3.1: Sequencing by Synthesis (SBS)
    • 3.3.2: Sequencing by Ligation (SBL)
    • 3.3.3: Nanopore Sequencing
    • 3.3.4: Sanger Sequencing
    • 3.3.5: Others
  • 3.4: Global Microbiome Sequencing Service Market by Type
    • 3.4.1: Amplicon Sequencing
    • 3.4.2: Whole-Genome Sequencing
    • 3.4.3: Shotgun Sequencing
    • 3.4.4: Others
  • 3.5: Global Microbiome Sequencing Service Market by End Use Industry
    • 3.5.1: Pharmaceutical and Biotechnology Companies
    • 3.5.2: Academic and Research Institutes
    • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2017 to 2028

  • 4.1: Global Microbiome Sequencing Service Market by Region
  • 4.2: North American Microbiome Sequencing Service Market
    • 4.2.1: North American Microbiome Sequencing Service Market by Technology: Sequencing by Synthesis (SBS), Sequencing by Ligation (SBL), and Nanopore Sequencing Sanger Sequencing
    • 4.2.2: North American Microbiome Sequencing Service Market by Type: Amplicon Sequencing, Whole-Genome Sequencing, Shotgun Sequencing, and Others
  • 4.3: European Microbiome Sequencing Service Market
  • 4.3: European Microbiome Sequencing Service Market
    • 4.3.1: European Microbiome Sequencing Service Market by Technology: Sequencing by Synthesis (SBS), Sequencing by Ligation (SBL), and Nanopore Sequencing Sanger Sequencing
    • 4.3.2: European Microbiome Sequencing Service Market by Type: Amplicon Sequencing, Whole-Genome Sequencing, Shotgun Sequencing, and Others
  • 4.4: APAC Microbiome Sequencing Service Market
    • 4.4.1: APAC Microbiome Sequencing Service Market by Technology: Sequencing by Synthesis (SBS), Sequencing by Ligation (SBL), and Nanopore Sequencing Sanger Sequencing
    • 4.4.2: APAC Microbiome Sequencing Service Market by Type: Amplicon Sequencing, Whole-Genome Sequencing, Shotgun Sequencing, and Others
  • 4.5: ROW Microbiome Sequencing Service Market
    • 4.5.1: ROW Microbiome Sequencing Service Market by Technology: Sequencing by Synthesis (SBS), Sequencing by Ligation (SBL), and Nanopore Sequencing Sanger Sequencing
    • 4.5.2: ROW Microbiome Sequencing Service Market by Type: Amplicon Sequencing, Whole-Genome Sequencing, Shotgun Sequencing, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Microbiome Sequencing Service Market by Technology
    • 6.1.2: Growth Opportunities for the Global Microbiome Sequencing Service Market by Type
    • 6.1.3: Growth Opportunities for the Global Microbiome Sequencing Service Market by End Use Industry
    • 6.1.4: Growth Opportunities for the Global Microbiome Sequencing Service Market by Region
  • 6.2: Emerging Trends in the Global Microbiome Sequencing Service Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Microbiome Sequencing Service Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Microbiome Sequencing Service Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Microbiome Insights
  • 7.2: Baseclear
  • 7.3: Clinical-Microbiomics
  • 7.4: Merieux NutriSciences Corporation
  • 7.5: MR DNA
  • 7.6: Metabiomics
  • 7.7: Rancho BioSciences
  • 7.8: Second Genome
  • 7.9: Zymo Research Corporation
  • 7.10: uBiome